Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer.
about
Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301Nab-Paclitaxel and Carboplatin (Nab-PC) Regimen for Advanced Non-Small-Cell Lung CancerA phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung CancerThe role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.Assessing the clinical outcome of nab-paclitaxel in Chinese patients with advanced non-small-cell lung cancer.
P2860
Q30376531-5762893E-3C59-4C79-B937-99B04EEB9264Q33427359-BA43682C-EA70-4720-9B41-8BB9D13CB6B4Q33442004-D7AA768C-C3AA-44FE-9049-3C7960942916Q34612764-F00585DC-B361-4409-B921-DF3E3504D442Q38390947-EFBD1C09-1834-4679-9A4C-DC393DDF7EB2Q38741016-762CB7AC-3339-4625-8786-6DDA2B1516FCQ41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9Q47100701-FD190CE1-30FC-4FF3-944C-70146944CBCCQ47253569-91967010-C72D-4611-BA07-39A9E263F867Q47608285-C32033C8-EB3B-4937-978A-5E91B127E66DQ51591928-86A20105-509D-44E5-B606-56231B362392
P2860
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@ast
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@en
type
label
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@ast
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@en
prefLabel
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@ast
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@en
P2093
P1433
P1476
Efficacy and safety of weekly ...... ed non-small cell lung cancer.
@en
P2093
Hironobu Ohmatsu
Hiroshi Sakai
Isamu Okamoto
Kazuo Kasahara
Koji Takeda
Miyako Satouchi
Naoyuki Nogami
Nobuyuki Yamamoto
Shunichi Negoro
Yukito Ichinose
P304
P356
10.1016/J.LUNGCAN.2013.02.020
P577
2013-03-30T00:00:00Z